IFRS operating profit vs Sales growth at constant exchange rates

In 2026, IFRS operating profit worldwide was 9,700 million CHF; sales growth at constant exchange rates was 17.8%.

Change the pair

Compare different indicators

The series

Over time

Global, spaced by time in 2026 . Different units, drawn on separate scales and clipped to the years both series publish — earlier history stays on each indicator's own page. Read the values, not the heights.

IFRS operating profit

Unit: million CHF · 1 observation

Line chart
IFRS operating profitIFRS operating profit. 1 observations from Q1 2026 to Q1 2026, ranging from 9,700 million CHF to 9,700 million CHF. million CHF 0 2,000 4,000 6,000 8,000 10,000 8 Jan 15 Jan 22 Jan 5 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 9,700
IFRS operating profitIFRS operating profit. 1 observations from Q1 2026 to Q1 2026, ranging from 9,700 million CHF to 9,700 million CHF. million CHF 0 3,000 6,000 9,000 12,000 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 9,700
IFRS operating profitIFRS operating profit. 1 observations from Q1 2026 to Q1 2026, ranging from 9,700 million CHF to 9,700 million CHF. million CHF 0 3,000 6,000 9,000 12,000 8 Jan 22 Mar Feb 2026 Mar 2026 9,700
View the underlying data
IFRS operating profit
Period Type Value
Q1 2026 Actual 9,700 million CHF
Source: Roche · CC BY 4.0 · Full series

Sales growth at constant exchange rates

Unit: % · 2 observations

Line chart
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 5 Feb 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 15 Jan 22 Jan 8 Feb 15 Feb 22 Feb 8 Mar 15 Mar 22 Mar 29 Mar 2026 Feb 2026 Mar 2026 3% 18%
Sales growth at constant exchange ratesSales growth at constant exchange rates. 2 observations from Q1 2026 to Q2 2026, ranging from 3% to 17.8%. Latest value 17.8% (Q2 2026). % 0 5 10 15 20 8 Jan 22 Mar Feb 2026 Mar 2026 3% 18%
View the underlying data
Sales growth at constant exchange rates
Period Type Value
Q1 2026 Actual 3%
Q2 2026 Actual 17.8%
Source: Roche, Sanofi · CC BY 4.0 · Full series

Shared periods

Side by side

Only one period is published for both series. Comparing anything else would mean comparing different years.

Period IFRS operating profit Sales growth at constant exchange rates
2026 9,700 million CHF 17.8%

Provenance

Where these numbers come from

IFRS operating profit

Operating profit determined under International Financial Reporting Standards.

2 observations in Global · source organisations: Roche

Sales growth at constant exchange rates

Percentage change in sales calculated at constant exchange rates over the specified period.

2 observations in Global · source organisations: Roche, Sanofi

Data published under CC BY 4.0. Series A as JSON · Series B as JSON

Keep exploring

Related